- Home
- CNTA vs DBD Comparison
CNTA vs DBD Comparison
Compare CNTA & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CNTA
- DBD
- Stock Information
- Founded
- CNTA 2020
- DBD 1859
- Country
- CNTA United Kingdom
- DBD United States
- Employees
- CNTA 86
- DBD N/A
- Industry
- CNTA Biotechnology: Pharmaceutical Preparations
- DBD EDP Services
- Sector
- CNTA Health Care
- DBD Technology
- Exchange
- CNTA Nasdaq
- DBD Nasdaq
- Market Cap
- CNTA 1.6B
- DBD 1.8B
- IPO Year
- CNTA 2021
- DBD N/A
- Fundamental
- Price
- CNTA $12.43
- DBD $51.80
- Analyst Decision
- CNTA Strong Buy
- DBD Strong Buy
- Analyst Count
- CNTA 11
- DBD 2
- Target Price
- CNTA $27.00
- DBD $65.00
- AVG Volume (30 Days)
- CNTA 1.2M
- DBD 160.6K
- Earning Date
- CNTA 08-12-2025
- DBD 08-06-2025
- Dividend Yield
- CNTA N/A
- DBD N/A
- EPS Growth
- CNTA N/A
- DBD N/A
- EPS
- CNTA N/A
- DBD N/A
- Revenue
- CNTA $15,000,000.00
- DBD $3,696,800,000.00
- Revenue This Year
- CNTA N/A
- DBD $2.02
- Revenue Next Year
- CNTA N/A
- DBD $1.96
- P/E Ratio
- CNTA N/A
- DBD N/A
- Revenue Growth
- CNTA 118.88
- DBD N/A
- 52 Week Low
- CNTA $8.46
- DBD $34.38
- 52 Week High
- CNTA $19.09
- DBD $52.30
- Technical
- Relative Strength Index (RSI)
- CNTA 47.36
- DBD 71.52
- Support Level
- CNTA $11.77
- DBD $51.09
- Resistance Level
- CNTA $13.06
- DBD $52.30
- Average True Range (ATR)
- CNTA 0.70
- DBD 0.93
- MACD
- CNTA 0.03
- DBD 0.04
- Stochastic Oscillator
- CNTA 51.21
- DBD 93.96
About CNTA Centessa Pharmaceuticals plc
Centessa Pharmaceuticals PLC is a clinical-stage pharmaceutical company. The company's pipeline assets include: SerpinPC for Hemophilia A, B; LB101 for Solid Tumors; ORX750 for Narcolepsy Type 1 (NT1) and other sleep disorders; MGX292 Pulmonary Arterial Hypertension (PAH); and Undisclosed for Solid Tumors.
About DBD Diebold Nixdorf Incorporated Common stock
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are Banking, which offers integrated solutions for financial institutions, and Retail, which offers solutions, software, and services that improve the checkout process for retailers. A majority of its revenue is generated from the Banking segment. Geographically, the company generates maximum revenue from Europe, Middle East, and Africa (EMEA), followed by the Americas and the Asia-Pacific region.